Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,282.60    -28.80 (-2.20%)
Bid:
1,283.00
Ask:
1,283.20
Spread: 0.20 (0.016%)
Market Cap: £219.94b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Pre Stabilisation Notice

15 May 2025 13:07

RNS Number : 8771I
HSBC Bank plc
15 May 2025
 

15th May 2025

 

HSBC Holdings plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer/Trustee:

HSBC Holdings plc

Guarantor:

NA

Aggregate nominal amount:

GBP Benchmark

Description:

Fixed due 22ND May 2033

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

15th May 2025

Stabilisation period expected to end no later than:

20th June 2025

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAGZGMKZKKGKZM
Date   Source Headline
2nd Jul 202512:01 pmRNSHolding(s) in Company
1st Jul 20255:23 pmRNSTransaction in Own Shares
30th Jun 20253:01 pmRNSTotal Voting Rights
30th Jun 20253:00 pmRNSDirector/PDMR Shareholding
27th Jun 20256:19 pmRNSHolding(s) in Company
24th Jun 20255:24 pmRNSTransaction in Own Shares
24th Jun 20253:15 pmRNSCapital Reduction- increase Distributable Reserves
23rd Jun 20255:21 pmRNSTransaction in Own Shares
23rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
20th Jun 20255:35 pmRNSTransaction in Own Shares
20th Jun 20258:00 amRNSPost Stabilisation Notice
18th Jun 20255:20 pmRNSTransaction in Own Shares
17th Jun 20255:20 pmRNSTransaction in Own Shares
16th Jun 20255:13 pmRNSTransaction in Own Shares
13th Jun 20255:22 pmRNSTransaction in Own Shares
12th Jun 20255:24 pmRNSTransaction in Own Shares
12th Jun 20258:00 amRNSPost Stabilisation Notice
11th Jun 20255:30 pmRNSTransaction in Own Shares
10th Jun 20255:10 pmRNSTransaction in Own Shares
9th Jun 20255:26 pmRNSTransaction in Own Shares
9th Jun 20251:00 pmRNSFirst Interim Dividend for 2025 - Exchange Rate
9th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20255:17 pmRNSTransaction in Own Shares
6th Jun 20258:00 amRNSPost Stabilisation Notice
6th Jun 20258:00 amRNSPost Stabilisation Notice
6th Jun 20257:00 amRNSGroup Chair Succession
5th Jun 20255:20 pmRNSTransaction in Own Shares
5th Jun 20254:40 pmRNSIssuance of contingent convertible securities
4th Jun 20255:19 pmRNSTransaction in Own Shares
3rd Jun 20255:25 pmRNSTransaction in Own Shares
3rd Jun 20259:03 amRNSHolding(s) in Company
2nd Jun 20255:22 pmRNSTransaction in Own Shares
30th May 20255:25 pmRNSTransaction in Own Shares
30th May 20254:00 pmRNSTotal Voting Rights
30th May 20257:00 amRNSPerpetual subordinated contingent conv securities
29th May 20255:20 pmRNSTransaction in Own Shares
28th May 20255:23 pmRNSTransaction in Own Shares
28th May 20254:00 pmRNSDirector/PDMR Shareholding
28th May 202512:30 pmRNSIssuance of senior unsecured notes
27th May 20255:18 pmRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSHolding(s) in Company
23rd May 20255:29 pmRNSTransaction in Own Shares
23rd May 20257:00 amRNSHolding(s) in Company
22nd May 20255:38 pmRNSTransaction in Own Shares
22nd May 20251:05 pmRNSIssuance of senior unsecured notes
21st May 20255:30 pmRNSTransaction in Own Shares
21st May 20254:00 pmRNSDirector Declaration
20th May 20255:19 pmRNSTransaction in Own Shares
19th May 20255:31 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.